Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oscar Blanco

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Blood Cancer Journal|June 19, 2019
Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomasMaría García-Álvarez, Sara Alonso-Álvarez, Isabel Prieto-Conde, et al.
Blood|February 3, 2025
IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapyMarcos Garcia-Lacarte, Sara C Grijalba, Javier Melchor Sánchez, et al.
Cancer Research|March 2, 2018
Loss of Pax5 Exploits Sca1-BCR-ABL<sup>p190</sup> Susceptibility to Confer the Metabolic Shift Essential for pB-ALLAlberto Martín-Lorenzo, Franziska Auer, Lai N Chan, et al.
Cancer Discovery|September 27, 2015
Infection Exposure is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5-Inherited SusceptibilityAlberto Martín-Lorenzo, Julia Hauer, Carolina Vicente-Dueñas, et al.
Blood|April 13, 2019
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomasMarién Pascual, María Mena-Varas, Eloy Francisco Robles, et al.
British Journal of Haematology|May 29, 2024
Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual diseaseMiguel Alcoceba, James P Stewart, María García-Álvarez, et al.
Scientific Reports|November 6, 2020
Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesisMarta Isidro-Hernández, Andrea Mayado, Ana Casado-García, et al.
Blood Cancer Journal|January 12, 2021
Genetic complexity impacts the clinical outcome of follicular lymphoma patientsMaría García-Álvarez, Sara Alonso-Álvarez, Isabel Prieto-Conde, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 7, 2026
Phenotypic Characterisation of Richter Transformation and De Novo Diffuse Large B-Cell Lymphoma With or Without Monoclonal B-cell LymphocytosisFernando Martin-Moro, Miguel Alcoceba, Samuel Romero, et al.
JCI Insight|February 17, 2026
Deletion 9p drives B-ALL through the heterozygous inactivation of Pax5 and Cd72 in pre-leukemic cellsBelén Ruiz-Corzo, Ana Casado-García, Ninad Oak, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Blood Cancer Journal|June 19, 2019
Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomasMaría García-Álvarez, Sara Alonso-Álvarez, Isabel Prieto-Conde, et al.
Blood|February 3, 2025
IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapyMarcos Garcia-Lacarte, Sara C Grijalba, Javier Melchor Sánchez, et al.
Cancer Research|March 2, 2018
Loss of Pax5 Exploits Sca1-BCR-ABL<sup>p190</sup> Susceptibility to Confer the Metabolic Shift Essential for pB-ALLAlberto Martín-Lorenzo, Franziska Auer, Lai N Chan, et al.
Cancer Discovery|September 27, 2015
Infection Exposure is a Causal Factor in B-cell Precursor Acute Lymphoblastic Leukemia as a Result of Pax5-Inherited SusceptibilityAlberto Martín-Lorenzo, Julia Hauer, Carolina Vicente-Dueñas, et al.
Blood|April 13, 2019
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomasMarién Pascual, María Mena-Varas, Eloy Francisco Robles, et al.
British Journal of Haematology|May 29, 2024
Liquid biopsy for molecular characterization of diffuse large B-cell lymphoma and early assessment of minimal residual diseaseMiguel Alcoceba, James P Stewart, María García-Álvarez, et al.
Scientific Reports|November 6, 2020
Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesisMarta Isidro-Hernández, Andrea Mayado, Ana Casado-García, et al.
Blood Cancer Journal|January 12, 2021
Genetic complexity impacts the clinical outcome of follicular lymphoma patientsMaría García-Álvarez, Sara Alonso-Álvarez, Isabel Prieto-Conde, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 7, 2026
Phenotypic Characterisation of Richter Transformation and De Novo Diffuse Large B-Cell Lymphoma With or Without Monoclonal B-cell LymphocytosisFernando Martin-Moro, Miguel Alcoceba, Samuel Romero, et al.
JCI Insight|February 17, 2026
Deletion 9p drives B-ALL through the heterozygous inactivation of Pax5 and Cd72 in pre-leukemic cellsBelén Ruiz-Corzo, Ana Casado-García, Ninad Oak, et al.
Pageof 8